Iterum Therapeutics Plc. (ITRM) NASDAQ
$1.54 (0.05) (-3.15%)
Market Cap: $21.36M
As of 03/28/24 04:00 PM EDT. Market closed.
Iterum Therapeutics Plc. (ITRM)
NASDAQ
$1.54
(0.05) (-3.15%)
Market Cap: $21.36M
As of 03/28/24 04:00 PM EDT. Market closed.
iterum therapeutics plc is an ireland-based clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives. these products are aimed at combatting the global crisis of multi-drug resistant (mdr) pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. iterum’s first product is a novel anti-infective ... read more
iterum therapeutics plc is an ireland-based clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives. these products are aimed at combatting the global crisis of multi-drug resistant (mdr) pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. iterum’s first product is a novel anti-infective compound that has demonstrated potent in-vitro activity vs. a wide variety of gram-negative, gram-positive and anaerobic bacteria resistant to other antibiotics. for more information on iterum therapeutics please visit www.iterumtx.com. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Dunne Michael W. | Director | Dec 22, 2023 | Buy | $1.40 | 25,000 | 35,000 | 113,754 | Dec 27, 2023, 09:00 AM |
Dunne Michael W. | Director | Dec 18, 2023 | Buy | $1.84 | 10,000 | 18,442 | 88,754 | Dec 19, 2023, 04:15 PM |
Puttagunta Sailaja | Chief Medical Officer | Dec 01, 2023 | Option Exercise | $2.12 | 2,933 | 6,218 | 10,369 | Dec 04, 2023, 05:00 PM |
Dunne Michael W. | Director | Nov 22, 2023 | Buy | $2.03 | 20,000 | 40,690 | 78,754 | Nov 27, 2023, 05:00 PM |
Fishman Corey N. | Chief Executive Officer | Nov 20, 2023 | Buy | $1.59 | 10,000 | 15,863 | 54,449 | Nov 20, 2023, 05:00 PM |
Matthews Judith M. | Chief Financial Officer | Mar 11, 2023 | Option Exercise | $0.96 | 2,883 | 2,768 | 8,135 | Mar 14, 2023, 06:00 PM |
Fishman Corey N. | Chief Executive Officer | Mar 11, 2023 | Option Exercise | $0.96 | 5,683 | 5,456 | 44,449 | Mar 14, 2023, 06:00 PM |
Puttagunta Sailaja | Chief Medical Officer | Dec 02, 2022 | Sale | $1.32 | 3,365 | 4,442 | 4,969 | Dec 05, 2022, 05:00 PM |
Ahrens Brenton Karl | Director | Sep 20, 2022 | Sale | $1.78 | 7,246 | 12,910 | 0 | Sep 20, 2022, 06:00 PM |
Ahrens Brenton Karl | Director | Sep 19, 2022 | Sale | $1.77 | 15,000 | 26,478 | 7,246 | Sep 20, 2022, 06:00 PM |
Ahrens Brenton Karl | Director | Sep 16, 2022 | Sale | $1.90 | 15,000 | 28,542 | 22,246 | Sep 20, 2022, 06:00 PM |
Ahrens Brenton Karl | Director | Sep 14, 2022 | Sale | $2.10 | 15,000 | 31,457 | 52,246 | Sep 15, 2022, 05:36 PM |
Ahrens Brenton Karl | Director | Sep 13, 2022 | Sale | $2.14 | 15,000 | 32,118 | 67,246 | Sep 15, 2022, 05:36 PM |
Ahrens Brenton Karl | Director | Sep 15, 2022 | Sale | $2.02 | 15,000 | 30,272 | 37,246 | Sep 15, 2022, 05:36 PM |
Ahrens Brenton Karl | Director | Sep 12, 2022 | Sale | $2.31 | 15,000 | 34,608 | 82,246 | Sep 12, 2022, 09:01 PM |
Ahrens Brenton Karl | Director | Sep 09, 2022 | Sale | $2.32 | 15,000 | 34,729 | 97,246 | Sep 12, 2022, 09:01 PM |
Ahrens Brenton Karl | Director | Sep 08, 2022 | Sale | $2.26 | 3,298 | 7,465 | 112,246 | Sep 12, 2022, 09:01 PM |
Dunne Michael W. | Director | Sep 07, 2022 | Buy | $2.22 | 10,000 | 22,200 | 35,576 | Sep 09, 2022, 06:00 PM |
Matthews Judith M. | Chief Financial Officer | Mar 14, 2022 | Sale | $0.31 | 63,340 | 19,635 | 65,292 | Mar 15, 2022, 07:12 PM |
Matthews Judith M. | Chief Financial Officer | Mar 14, 2022 | Sale | $0.38 | 47,132 | 17,910 | 81,500 | Mar 15, 2022, 05:01 PM |
DENNER ALEXANDER J | 10% Owner | Feb 12, 2021 | Sale | $2.27 | 10,619,949 | 24,107,284 | 0 | Feb 12, 2021, 08:22 PM |
DENNER ALEXANDER J | 10% Owner | Feb 11, 2021 | Sale | $2.59 | 10,000,000 | 25,899,999 | 10,619,949 | Feb 12, 2021, 08:22 PM |
Fishman Corey N. | President & CEO | Jan 26, 2021 | Sale | $1.73 | 85,445 | 147,820 | 322,008 | Jan 27, 2021, 07:35 PM |
Dunne Michael W. | Director | Jan 26, 2021 | Sale | $1.73 | 33,143 | 57,337 | 256,355 | Jan 27, 2021, 07:32 PM |
Matthews Judith M. | Chief Financial Officer | Jan 26, 2021 | Sale | $1.73 | 33,868 | 58,592 | 28,632 | Jan 27, 2021, 07:32 PM |
Matthews Judith M. | Chief Financial Officer | Sep 30, 2020 | Sale | $1.64 | 56,130 | 92,053 | 0 | Oct 02, 2020, 09:00 PM |
Sofinnova Venture Partners IX, L.P. | 10% Owner | Jun 02, 2020 | Sale | $1.61 | 400,000 | 642,960 | 1,226,514 | Jun 03, 2020, 08:20 PM |
Sofinnova Venture Partners IX, L.P. | 10% Owner | Jun 01, 2020 | Sale | $1.69 | 100,000 | 169,120 | 1,626,514 | Jun 03, 2020, 08:20 PM |
Kelly David George | Director | Nov 30, 2018 | Buy | $6.29 | 10,000 | 62,887 | 19,548 | Dec 04, 2018, 05:48 PM |
Chin Mark | Director | Oct 30, 2018 | Buy | $6.10 | 58,000 | 353,800 | 1,089,903 | Nov 01, 2018, 05:25 PM |
Dunne Michael W. | Chief Scientific Officer | Sep 04, 2018 | Buy | $10.00 | 500 | 5,000 | 147,958 | Sep 06, 2018, 05:11 PM |
Dunne Michael W. | Chief Scientific Officer | Aug 27, 2018 | Buy | $10.00 | 500 | 5,000 | 147,458 | Aug 28, 2018, 05:18 PM |
Dunne Michael W. | Chief Scientific Officer | Aug 24, 2018 | Buy | $10.00 | 500 | 5,000 | 146,958 | Aug 28, 2018, 05:18 PM |
Edick Paul R | Director | Aug 23, 2018 | Buy | $10.44 | 500 | 5,219 | 25,236 | Aug 27, 2018, 05:15 PM |
Fishman Corey N. | President & CEO | Aug 17, 2018 | Buy | $8.73 | 2,000 | 17,466 | 239,953 | Aug 21, 2018, 10:44 AM |
Chin Mark | Director | May 30, 2018 | Buy | $13.00 | 337,606 | 4,388,878 | 1,031,903 | Jun 01, 2018, 03:37 PM |
Lathi Vijay K | 10% Owner | May 30, 2018 | Buy | $13.00 | 278,062 | 3,614,806 | 1,071,688 | May 31, 2018, 04:54 PM |
Lathi Vijay K | 10% Owner | May 30, 2018 | Buy | $13.00 | 384,615 | 4,999,995 | 384,615 | May 31, 2018, 04:54 PM |
HUNT RONALD | Director | May 30, 2018 | Buy | $13.00 | 384,615 | 4,999,995 | 384,615 | May 31, 2018, 04:52 PM |
HUNT RONALD | Director | May 30, 2018 | Buy | $13.00 | 278,062 | 3,614,806 | 1,071,688 | May 31, 2018, 04:52 PM |
Sofinnova Venture Partners IX, L.P. | 10% Owner | May 30, 2018 | Buy | $13.00 | 500,000 | 6,500,000 | 1,726,514 | May 30, 2018, 09:59 PM |
HEALY JAMES | Director | May 30, 2018 | Buy | $13.00 | 500,000 | 6,500,000 | 1,726,514 | May 30, 2018, 05:32 PM |
Malik Shahzad | Director | May 30, 2018 | Buy | $13.00 | 228,840 | 2,974,920 | 838,325 | May 30, 2018, 05:29 PM |
Malik Shahzad | Director | May 30, 2018 | Buy | $13.00 | 8,144 | 105,872 | 29,836 | May 30, 2018, 05:29 PM |
Ahrens Brenton Karl | Director | May 30, 2018 | Buy | $13.00 | 506,656 | 6,586,528 | 1,733,170 | May 30, 2018, 05:26 PM |
CANAAN X L.P. | Director | May 30, 2018 | Buy | $13.00 | 506,656 | 6,586,528 | 1,733,170 | May 30, 2018, 05:25 PM |
Heron Patrick J | Director | May 30, 2018 | Buy | $13.00 | 101,150 | 1,314,950 | 341,155 | May 30, 2018, 05:15 PM |
Heron Patrick J | Director | May 30, 2018 | Buy | $13.00 | 354,949 | 4,614,337 | 1,197,161 | May 30, 2018, 05:15 PM |
Matthews Judith M. | Chief Financial Officer | May 30, 2018 | Buy | $13.00 | 4,000 | 52,000 | 56,130 | May 30, 2018, 05:12 PM |
Dunne Michael W. | Chief Scientific Officer | May 30, 2018 | Buy | $13.00 | 2,000 | 26,000 | 146,458 | May 30, 2018, 05:02 PM |
Fishman Corey N. | President & CEO | May 30, 2018 | Buy | $13.00 | 3,000 | 39,000 | 237,953 | May 30, 2018, 05:01 PM |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
RENAISSANCE TECHNOLOGIES LLC | 49,922 | 0.00015% | 6.39% | Other |
Period of Report: 09/30/2023
10-K/10-Q Filings: View